Telomerase maintains telomere structure in normal human cells.

PubWeight™: 3.29‹?› | Rank: Top 1%

🔗 View Article (PMID 12887925)

Published in Cell on July 25, 2003

Authors

Kenkichi Masutomi1, Evan Y Yu, Shilagardy Khurts, Ittai Ben-Porath, Jennifer L Currier, Geoffrey B Metz, Mary W Brooks, Shuichi Kaneko, Seishi Murakami, James A DeCaprio, Robert A Weinberg, Sheila A Stewart, William C Hahn

Author Affiliations

1: Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

Articles citing this

(truncated to the top 100)

The essence of senescence. Genes Dev (2010) 8.21

An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature (2009) 3.04

Telomeres, stem cells, senescence, and cancer. J Clin Invest (2004) 2.87

DNA specificity determinants associate with distinct transcription factor functions. PLoS Genet (2009) 2.56

What has senescence got to do with cancer? Cancer Cell (2005) 2.55

Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer (2008) 2.54

When cells get stressed: an integrative view of cellular senescence. J Clin Invest (2004) 2.37

Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell (2005) 2.26

Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol (2004) 2.23

Telomerase RNA accumulates in Cajal bodies in human cancer cells. Mol Biol Cell (2003) 2.14

The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci U S A (2005) 2.01

Does a sentinel or a subset of short telomeres determine replicative senescence? Mol Biol Cell (2004) 1.92

Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Gynecol Oncol (2011) 1.87

Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc Natl Acad Sci U S A (2004) 1.83

Transformation of human and murine fibroblasts without viral oncoproteins. Mol Cell Biol (2005) 1.81

Regulation of the human catalytic subunit of telomerase (hTERT). Gene (2012) 1.81

Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc Natl Acad Sci U S A (2007) 1.80

POT1 and TRF2 cooperate to maintain telomeric integrity. Mol Cell Biol (2005) 1.74

Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol Cell Biol (2007) 1.71

Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophages. Arterioscler Thromb Vasc Biol (2010) 1.70

Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging (Albany NY) (2011) 1.58

The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci U S A (2005) 1.56

Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev (2004) 1.50

Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev (2004) 1.48

Telomerase- and recombination-independent immortalization of budding yeast. Genes Dev (2004) 1.47

The Mre11 complex mediates the S-phase checkpoint through an interaction with replication protein A. Mol Cell Biol (2007) 1.38

Transcriptional networks and cellular senescence in human mammary fibroblasts. Mol Biol Cell (2004) 1.38

Processive and distributive extension of human telomeres by telomerase under homeostatic and nonequilibrium conditions. Mol Cell (2011) 1.26

Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling. Mol Cell Biol (2004) 1.25

A transcriptional program mediating entry into cellular quiescence. PLoS Genet (2007) 1.23

Telomeres and immunological diseases of aging. Gerontology (2009) 1.22

Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells. Mol Biol Cell (2008) 1.22

Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms. PLoS One (2010) 1.19

Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. Br J Cancer (2007) 1.18

Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells. Mol Cancer Res (2008) 1.18

The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted. J Cell Biol (2007) 1.17

Genome-wide association study of relative telomere length. PLoS One (2011) 1.16

Protein 4.1B suppresses prostate cancer progression and metastasis. Proc Natl Acad Sci U S A (2007) 1.16

FEN1 ensures telomere stability by facilitating replication fork re-initiation. J Biol Chem (2010) 1.14

Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence? J Clin Invest (2004) 1.14

Chromosome 7 and 19 trisomy in cultured human neural progenitor cells. PLoS One (2009) 1.13

From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther (2012) 1.12

Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics (2011) 1.08

Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell (2010) 1.07

Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. FASEB J (2010) 1.07

Use of exogenous hTERT to immortalize primary human cells. Cytotechnology (2004) 1.06

Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome. Aging Cell (2007) 1.05

Paternal age at birth is associated with offspring leukocyte telomere length in the nurses' health study. Hum Reprod (2012) 1.03

Permanent embryo arrest: molecular and cellular concepts. Mol Hum Reprod (2008) 1.03

Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria. Front Oncol (2012) 1.02

Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telomerase reverse transcriptase expression/telomerase activation induced by proliferation. Mol Cell Biol (2006) 1.01

The replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses. Aging Cell (2014) 1.00

Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line. Int J Cancer (2010) 1.00

Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Res (2011) 0.98

Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity. Oncotarget (2013) 0.97

Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation. J Biol Chem (2010) 0.96

Differential repression of human and mouse TERT genes during cell differentiation. Nucleic Acids Res (2009) 0.95

Telomeric armor: the layers of end protection. J Cell Sci (2009) 0.95

Making the most of a little: dosage effects in eukaryotic telomere length maintenance. Chromosome Res (2005) 0.95

Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT. Blood (2005) 0.94

Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species. Cell Death Dis (2013) 0.94

Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells. Proc Natl Acad Sci U S A (2006) 0.94

Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response. Mol Cell Proteomics (2009) 0.93

Dbf4 is direct downstream target of ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) protein to regulate intra-S-phase checkpoint. J Biol Chem (2011) 0.93

Regulation of cellular immortalization and steady-state levels of the telomerase reverse transcriptase through its carboxy-terminal domain. Mol Cell Biol (2006) 0.93

Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex. Elife (2014) 0.93

Dual roles of c-Myc in the regulation of hTERT gene. Nucleic Acids Res (2014) 0.92

Functional genetic screen for genes involved in senescence: role of Tid1, a homologue of the Drosophila tumor suppressor l(2)tid, in senescence and cell survival. Mol Cell Biol (2004) 0.92

Immortalization of epithelial progenitor cells mediated by resveratrol. Oncogene (2007) 0.92

Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells. Proc Natl Acad Sci U S A (2004) 0.92

ZEB2 Represses the Epithelial Phenotype and Facilitates Metastasis in Ewing Sarcoma. Genes Cancer (2013) 0.91

Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds. Biochimie (2008) 0.91

Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors. Mol Ther (2013) 0.90

Telomerase expression is sufficient for chromosomal integrity in cells lacking p53 dependent G1 checkpoint function. J Carcinog (2005) 0.90

High incidence of rapid telomere loss in telomerase-deficient Caenorhabditis elegans. Nucleic Acids Res (2006) 0.90

DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability? Stem Cells Int (2013) 0.90

Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis. Neuro Oncol (2012) 0.89

HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs. J Virol (2012) 0.89

Dual roles of telomere dysfunction in initiation and suppression of tumorigenesis. Exp Cell Res (2008) 0.89

ATR contributes to telomere maintenance in human cells. Nucleic Acids Res (2010) 0.88

Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress. Curr Cardiol Rev (2008) 0.88

Effect of vector-expressed shRNAs on hTERT expression. World J Gastroenterol (2005) 0.88

The emerging role of telomerase reverse transcriptase in mitochondrial DNA metabolism. J Nucleic Acids (2010) 0.88

Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Curr Pharmacogenomics Person Med (2010) 0.87

Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene. PLoS One (2010) 0.87

Telomerase inhibition in cancer therapeutics: molecular-based approaches. Curr Med Chem (2006) 0.87

High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer (2004) 0.86

Rad50 zinc hook is important for the Mre11 complex to bind chromosomal DNA double-stranded breaks and initiate various DNA damage responses. J Biol Chem (2012) 0.86

Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop. Exp Cell Res (2006) 0.86

Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts. J Cancer Res Clin Oncol (2015) 0.86

Metabolism, longevity and epigenetics. Cell Mol Life Sci (2013) 0.85

Involvement of telomerase reverse transcriptase in heterochromatin maintenance. Mol Cell Biol (2014) 0.85

Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway. Oncogene (2014) 0.85

Decreased sensitivity of 17p-deleted chronic lymphocytic leukemia cells to a small molecule BCL-2 antagonist ABT-737. Cancer (2011) 0.84

Telomerase enzymatic component hTERT shortens long telomeres in human cells. Cell Cycle (2014) 0.84

Function, replication and structure of the mammalian telomere. Cytotechnology (2004) 0.84

Mechanism of telomerase activation by v-Rel and its contribution to transformation. J Virol (2006) 0.84

Therapeutic targeting of replicative immortality. Semin Cancer Biol (2015) 0.83

Hereditary profiles of disorderly transcription? Biol Direct (2006) 0.83

Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma. World J Gastroenterol (2006) 0.82

Articles by these authors

Hallmarks of cancer: the next generation. Cell (2011) 140.01

The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08

The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell (2004) 31.38

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 21.53

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell (2006) 18.81

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer (2009) 18.53

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell (2005) 18.20

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67

Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28

Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20

Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med (2012) 15.69

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature (2007) 15.20

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell (2008) 14.80

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature (2010) 14.62

BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell (2011) 14.34

A perspective on cancer cell metastasis. Science (2011) 13.31

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature (2006) 11.90

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature (2009) 11.46

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. Lancet (2010) 10.79

Retracted A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell (2009) 10.51

Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34

A progression puzzle. Nature (2002) 9.56

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol (2011) 8.37

Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA (2003) 8.07

Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A (2004) 7.96

Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res (2008) 7.91

Ras oncogenes: split personalities. Nat Rev Mol Cell Biol (2008) 7.91

Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell (2007) 7.60

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet (2009) 7.48

Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci U S A (2008) 7.45

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol (2010) 6.67

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol (2004) 6.61

Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell (2009) 6.55

CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A (2010) 6.15

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med (2005) 6.04

Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods (2006) 5.96

Profiling critical cancer gene mutations in clinical tumor samples. PLoS One (2009) 5.63

Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A (2011) 5.53

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology (2008) 5.53

Modelling the molecular circuitry of cancer. Nat Rev Cancer (2002) 5.43

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov (2011) 5.30

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A (2007) 5.24

Cancer stem cells: mirage or reality? Nat Med (2009) 5.20

The signals and pathways activating cellular senescence. Int J Biochem Cell Biol (2004) 5.00

A public genome-scale lentiviral expression library of human ORFs. Nat Methods (2011) 4.98

Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood (2010) 4.96

Rules for making human tumor cells. N Engl J Med (2002) 4.84

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol (2010) 4.80

Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell (2011) 4.79

Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol (2002) 4.77

Slug and Sox9 cooperatively determine the mammary stem cell state. Cell (2012) 4.77

Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. Cancer Cell (2008) 4.71

AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell (2009) 4.71

The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet (2005) 4.70

Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell (2006) 4.68

Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle (2006) 4.67

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology (2010) 4.58

Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell (2006) 4.52

Regulation of in situ to invasive breast carcinoma transition. Cancer Cell (2008) 4.46

The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. J Clin Invest (2011) 4.41

Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature (2012) 4.35

The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One (2008) 4.32

Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell (2007) 4.30

Species- and cell type-specific requirements for cellular transformation. Cancer Cell (2004) 4.25

Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci U S A (2011) 4.15

Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods (2006) 4.12

Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med (2002) 4.04

Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol (2012) 3.98

The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med (2013) 3.96

Exploring a new twist on tumor metastasis. Cancer Res (2006) 3.96

Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell (2008) 3.95

Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene (2002) 3.80

Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell (2008) 3.75

The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A (2006) 3.64

Chemosensitivity linked to p73 function. Cancer Cell (2003) 3.63

Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell (2013) 3.61

Retracted Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell (2003) 3.56

Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev (2012) 3.44

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial. Lancet Oncol (2013) 3.38

Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell (2003) 3.33

β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell (2012) 3.33

Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell (2004) 3.29

Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer (2003) 3.23

Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell (2003) 3.23

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet (2013) 3.19

An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med (2010) 3.09

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2. Proc Natl Acad Sci U S A (2012) 3.06

An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature (2009) 3.04

Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Res (2007) 3.04